longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

22nd Century Group shares are trading lower after the company annoucned it filed a prospectus to sell up to $6.4 millions shares under a sales agreement.

benzinga_article
May 4, 2026 at 12:44 PM
22nd Century Group shares are trading lower after the company annoucned it filed a prospectus to sell up to $6.4 millions shares under a sales agreement.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)
  • Apr 7, 2026 at 03:50 PMGoldman Sachs Issues Rare Call: "Generational Buying Opportunity" for US Tech Stocks Has Quietly Begun
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting

Related Stocks

22nd Century

22nd Century

USXXII

-5.18%

Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF

USPBE

ALPS Medical Breakthrough

ALPS Medical Breakthrough

USSBIO

LongbridgeAI